Skip to main content
. 2024 Aug 29;15:7483. doi: 10.1038/s41467-024-51718-7

Table 1.

Human PHD2 serum protein levels are positively correlated with metabolic syndrome related traits

Model* Outcome variable N β coef. 95% CI S.E. P value
Linear regression
Body mass index, kg/m2 5439 0.356 (0.234, 0.478) 0.062 1.17E-08
Visceral fat area, cm2 5228 8.220 (6.085, 10.355) 1.089 5.20E-14
Triglyceride serum, mmol/L 5447 0.066 (0.048, 0.084) 0.009 6.33E-13
Fasting glucose, mmol/L 5447 0.063 (0.031, 0.095) 0.016 1.05E-04
HbA1c, g/dl 5019 0.009 (0.006, 0.012) 0.001 4.22E-11
Insulin serum, µU/ml 5446 1.127 (0.832, 1.422) 0.150 7.36E-14
Logistic regression
Type II diabetes 5447 1.191 (1.094, 1.297) 0.052 5.76E-05
IFG (5.6–6.9 mmol/L) 4787 1.057 (0.994, 1.124) 0.033 7.53E-02
Metabolic syndrome 5443 1.260 (1.186, 1.340) 0.039 9.71E-14

N number of individuals with outcome data, CI confidence intervals, S.E. standard error, IFG impaired fasting glucose.

*Models were adjusted for PHD2, age and sex. PHD2 beta coefficients for continuous outcome variables are from a linear regression. For dichotomous outcome variables the PHD2 beta coefficients are odds ratios from logistic regression (see “Methods” for more details on the summary statistics). P values are two-sided.

Serum protein PHD2 levels were correlated with BMI, visceral adiposity, triglycerides, fasting glucose, HBA1C, insulin, type II diabetes and metabolic syndrome in the population-based Age, Gene/Environment Susceptibility (AGES) study.